Lifestyle and metabolic approaches to maximizing erectile and vascular health

International Journal of Impotence Research

Volumn 24, Issue 2, 2012, Pages 61-68

  Meldrum, D R ^a,b   Gambone, J C ^a,b   Morris, M A ^a   Esposito, K ^a   Giugliano, D ^a   Ignarro, L J ^b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ED; inflammatory markers; lifestyle; nitric oxide; oxidative stress; PDE 5 inhibitors

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; FAT; FOLIC ACID; GLUCOSE; NITRIC OXIDE; OMEGA 3 FATTY ACID; PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE V INHIBITOR; POLYPHENOL; TESTOSTERONE;

AGING; BLOOD PRESSURE; DIET SUPPLEMENTATION; ERECTILE DYSFUNCTION; EXERCISE; FAT INTAKE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERHOMOCYSTEINEMIA; KIDNEY FAILURE; LIFESTYLE MODIFICATION; OBESITY; OXIDATIVE STRESS; PATIENT SATISFACTION; PENIS ERECTION; PRIORITY JOURNAL; REVIEW; SMOKING CESSATION; SUGAR INTAKE; WEIGHT REDUCTION;

AGING; ALCOHOL DRINKING; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANTIOXIDANTS; DIET, CARBOHYDRATE-RESTRICTED; DIET, FAT-RESTRICTED; ERECTILE DYSFUNCTION; EXERCISE; FATTY ACIDS, OMEGA-3; HUMANS; LIFE STYLE; MALE; NITRIC OXIDE; OXIDATIVE STRESS; PHOSPHODIESTERASE 5 INHIBITORS; RENAL INSUFFICIENCY; SMOKING CESSATION; TESTOSTERONE; VASCULAR DISEASES; WEIGHT LOSS;

EID: 84858699862     PISSN: 09559930     EISSN: 14765489     Source Type: Journal    
DOI: 10.1038/ijir.2011.51     Document Type: Review

References (75)

1. Rajfer J, Aronson WJ, Bush PA, Dorey FJ, Ignarro LJ. Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. N Engl J Med 1992; 326: 90-94.
2. Tagliabue M, Pinach S, Di Bisceglie C, Brocato L, Cassader M, Bertagna A et al. Glutathione levels in patients with erectile dysfunction, with or without diabetes mellitus. Int J Androl 2005; 28: 156-162. (Pubitemid 40780342)
3. Ciftci H, Yeni E, Savas M, Verit A, Celik H. Paraoxinase activity in patients with erectile dysfunction. Int J Impot Res 2007; 19: 517-520. (Pubitemid 47367529)
4. Soran H, Jounis NN, Charlton-Menys V, Durrington P. Variation in paraoxonase-1 activity and atherosclerosis. Curr Opin Lipidol 2009; 20: 265-274.
5. Aldemir M, Okulu E, Neselioglu S, Erel O, Ener K, Kayigil O. Evaluation of serum oxidative and antioxidative status in patients with erectile dysfunction. Andrologia 2011; e-pub ahead of print 30 June; doi: 10.1111/j.1439-0272.2011.01174.x.
6. Giugliano F, Esposito K, Di Palo C, Ciotola M, Giugliano G, Marfella R et al. Erectile dysfunction associates with endothelial dysfunction and raised proinflammatory cytokines in obese men. J Endocrinol Invest 2004; 27: 665-669. (Pubitemid 39359830)
7. Chiurlia E, D'Amico R, Ratti C, Granata AR, Romagnoli R, Modena MG. Subclinical coronary artery atherosclerosis in patients with erectile dysfunction. J Am Coll Cardiol 2005; 46: 1503-1506. (Pubitemid 41446186)
8. Ungvari Z, Parrado-Fernandez C, Csiszar A, de Cabo R. Mechanisms underlying caloric restriction and life span regulation: Implications for vascular aging. Circ Res 2008; 102: 519-528.
9. Esposito K, Giugliano F, Martedi E, Feola G, Marfella R, D'Armiento M et al. High proportions of erectile dysfunction in men with the metabolic syndrome. Diabetes Care 2005; 28: 1201-1203. (Pubitemid 40616635)
10. Muniyappa R, Quon MJ. Insulin action and insulin resistance in vascular endothelium. Curr Opin Clin Nutr Metab Care 2007; 10: 523-530. (Pubitemid 46934125)
11. Katz D, Doughty K, Ali A. Cocoa and chocolate in human health and disease. Antioxid Redox Signal 2011; 15: 2779-2811.
12. Potenza MA, MarasciuloFL, Tarquinio M, Tiravanti E, Colantuono G, Federici A et al. EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR. Am J Physiol Endocrinol Metab 2007; 292: E1378-E1387. (Pubitemid 46684607)
13. Esposito K, Giugliano F, Di Palo C, Giugliano G, Marfella R, D'Andrea F et al. Effect of lifestyle changes on erectile dysfunction in obese men: A randomized controlled study. JAMA 2004; 291: 2978-2984. (Pubitemid 38802687)
14. Roberts CK, Nosratola D, Vaziri MD, Barnard J. Effect of diet and exercise intervention on blood pressure, insulin, oxidative stress, and nitric oxide availability. Circulation 2002; 106: 2530-2532. (Pubitemid 35340686)
15. Ignarro LJ, Balestrieri ML, Napoli C. Nutrition, physical activity and cardiovascular disease: An update. Cardiovasc Res 2007; 73: 326-340. (Pubitemid 44970442)
16. Meldrum DR, Gambone JC, Morris MA, Meldrum DAN, Esposito K, Ignarro LJ. The link between erectile and cardiovascular health: The canary in the coal mine. Am J Cardiol 2011; 108: 599-606.
17. Buga GM, Gold ME, Fukuto JM, Ignarro LJ. Shear stressinduced release of nitric oxide from endothelial cells grown on beads. Hypertension 1991; 17: 187-193.
18. Koskimaki J, Shiri R, Tammela T, Hakkinen J, Hakama M, Auvinen A. Regular intercourse protects against erectile dysfunction: Tampere Aging Male Urologic Study. Am J Med 2008; 121: 592-596.
19. Yuan J, Hoang AN, Romero CA, Lin H, Dai Y, Wang R. Vacuum therapy in erectile dysfunction-science and clinical evidence. Int J Impot Res 2010; 22: 211-219.
20. Pace G, Del Rosso A, Vicentini C. Penile rehabilitation therapy following radical prostatectomy. Disabil Rehab 2010; 32: 1204-1208.
21. Dorey G, Speakman MJ, Feneley RCL, Swinkels A, Dunn CDR. Pelvic floor exercises for erectile dysfunction. BJU Int 2005; 96: 595-597. (Pubitemid 41224333)
22. Selvin E, Burnett AL, Platz EA. Prevalence and risk factors for erectile dysfunction in the US. Am J Med 2007; 120: 151-157. (Pubitemid 46175775)
23. Bacon CG, Mittleman MA, Kawachi I, Giovannucci E, Glasser DB, Rimm EB. Sexual function in men older than 50 years of age: Results from the health professionals follow-up study. Ann Intern Med 2003; 139: 161-168.
24. Agostini LCM, Netto JMB, Miranda MV, Figueiredo AA. Erectile dysfunction association with physical activity level and physical fitness in men aged 40-75 years. Int J Impot Res 2011; 23: 115-121.
25. Akkus E, Kadioglu A, Esen A, Doran S, Ergen A, Anafarta K, et al. (Turkish Erectile Dysfunction Prevalence Study Group). Prevalence and correlates of erectile dysfunction in Turkey: A population-based study. Eur Urol 2002; 41: 298-304. (Pubitemid 35303429)
26. Senti M, Tomas M, Anglada R, Elosua R, Marrugat J, Covas MI et al. Interrelationship of smoking, paraoxinase activity, and leisure time physical activity: A population-based study. Eur J Intern Med 2003; 14: 178-184. (Pubitemid 36677614)
27. Haram PM, Adams V, Kemi OJ, Brubakk AO, Hambrecht R, Ellingsen O et al. Time-course of endothelial adaptation following acute and regular exercise. Eur J Cardiovasc Prev Rehab 2006; 13: 585-591. (Pubitemid 44162161)
28. Esposito K, Ciotola M, Sasso FC, Cozzolino D, Saccomanno F, Assaloni R et al. Effect of a single high-fat meal on endothelial function in patients with the metabolic syndrome: Role of tumor necrosis factor-alpha. Nutr Metab Cardiovasc Dis 2007; 17: 274-279. (Pubitemid 46551687)
29. Johnson BD, Padilla J, Harris RA, Wallace JP. Vascular consequences of a high-fat meal in physically active and inactive adults. Appl Physiol Nutr Metab 2011; 36: 368-375.
30. Nappo F, Esposito K, Cioffi M, Giugliano G, Molinari AM, Paolisso G et al. Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: Role of fat and carbohydrate meals. J Am Coll Cardiol 2002; 39: 1145-1150. (Pubitemid 34267417)
31. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: Role of oxidative stress. Circulation 2002; 106: 2067-2072. (Pubitemid 35192812)
32. Giugliano F, Maiorino M, Bellastella G, Gicchino M, Giugliano D, Esposito K. Determinants of erectile dysfunction in type 2 diabetes. Int J Impot Res 2010; 22: 204-209.
33. Flammer AJ, Hermann F, Wiesli P, Schwegler B, Chenevard R, Hurlimann D et al. Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension. J Hypertens 2007; 25: 785-791. (Pubitemid 46398873)
34. Akishita M, Hashimoto M, Ohike Y, Ogawa S, Iijima K, Eto M et al. Low testosterone level is an independent determinant of endothelial dysfunction in men. Hypertens Res 2007; 30: 1029-1034.
35. Stanworth RD, Jones TH. Testosterone for the aging male: Current evidence and recommended practice. Clin Interv Aging 2008; 3: 25-44. (Pubitemid 351559801)
36. Rosenthal BD, May NR, Metro MJ, Harkaway RC, Gindberg PC. Adjunctive use of androgel (testosterone gel) with sildenafil to treat erectile dysfunction in men with acquired androgen deficiency syndrome after failure using sildenafil alone. Urology 2006; 67: 571-574. (Pubitemid 43343545)
37. Feldman HA, Johannes CB, Derby CA, Kleinman KP, Mohr BA, Araujo AB et al. Erectile dysfunction and coronary risk factors: Prospective results from the Massachusetts male aging study. Prev Med 2000; 30: 328-338. (Pubitemid 30211093)
38. Peluffo G, Calcerrada P, Piacenza L, Pizzano N, Radi F. Superoxide-mediated inactivation of nitric oxide and peroxynitrite formation by tobacco smoke in vascular endothelium: Studies in cultured cells and smokers. Am J Physiol Heart Circ Physiol 2009; 296: H1781-H1792.
39. Napoli C, Ignarro LJ. Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases. Arch Pharm Res 2009; 32: 1103-1108.
40. Ignarro LJ, Byrns RE, Sumi D, de Nigris F, Napoli C. Pomegranate juice protects nitric oxide against oxidative destruction and enhances the biologic actions of nitric oxide. Nitric Oxide 2006; 15: 93-102. (Pubitemid 44175887)
41. Cheng JYW, Ng EML, Chen RL, Ko JSN. Alcohol consumption and erectile dysfunction: Meta-analysis of population-based studies. Int J Impot Res 2007; 19: 343-352. (Pubitemid 47026091)
42. Abou-agag LH, Khoo NK, Binsack R, White CR, Darley-Usmar V, Grenett HE et al. Evidence of cardiovascular protection by moderate alcohol: Role of nitric oxide. Free Radic Biol Med 2005; 39: 540-548. (Pubitemid 41021652)
43. Aydinoglu F, Yilmaz SN, Coskun B, Daglioglu N, Ogulener N. Effects of ethanol treatment on the neurogenic and endothelium-dependent relaxation of corpus cavernosum smooth muscle in the mouse. Pharmacol Rep 2008; 60: 725-734.
44. Christensen BS, Gronbaek M, Pedersen BV, Graugaard C, Frisch M. Associations of unhealthy lifestyle factors with sexual inactivity and sexual dysfunctions in Denmark. J Sex Med 2011; 8: 1903-1916.
45. Faridi Z, Njike VY, Dutta S, Ali A, Katz DL. Acute dark chocolate and cocoa ingestion and endothelial function: A randomized controlled crossover trial. Am J Clin Nutr 2008; 88: 58-63. (Pubitemid 351988683)
46. Persson IA, Josefsson M, Persson K, Andersson RG. Tea flavanols inhibit angiotensin-converting enzyme activity and increase nitric oxide production in human endothelial cells. J Pharm Pharmacol 2006; 58: 1139-1144. (Pubitemid 44213648)
47. Mukamal KJ, Maclure M, Muller JE, Sherwood JB, Mittleman MA. Tea consumption and mortality after acute myocardial infarction. Circulation 2002; 105: 2476-2481. (Pubitemid 34568967)
48. Wallerath T, Poleo D, Li H, Forstermann U. Red wine increases the expression of human endothelial nitric oxide synthase: Amechanism that may contribute to its beneficial cardiovascular effects. J Am Coll Cardiol 2003; 41: 471-478. (Pubitemid 36164505)
49. Halvorsen BL, Carlsen MH, Phillips KM, Bohn SK, Holte K, Jacobs DR et al. Content of redox-active compounds (ie, antioxidants) in foods consumed in the United States. Am J Clin Nutr 2006; 84: 95-135. (Pubitemid 44699176)
50. Meldrum DR, Gambone JC, Morris MA, Ignarro LJ. A multifaceted approach to maximize erectile function and vascular health. Fertil Steril 2010; 94: 2514-2520.
51. Duffy SJ, Gokce N, Holbrook M, Huang A, Frei B, Keaney JF et al. Treatment of hypertension with ascorbic acid. Lancet 1999; 354: 2048-2049.
52. Moens AL, Vrints CJ, Claeys MJ, Timmermans JP, Kass DA. Mechanisms and potential therapeutic targets for folic acid in cardiovascular disease. Am J Physiol Heart Circ Physiol 2008; 249: H1971-H1977.
53. Safarinejad MR, Safarinejad S, Shafiei N. Role of methylenetetrahydrofolate reductase gene polymorphisms (C677T, A1298C, and G1793A) in the development of early onset vasculogenic erectile dysfunction. Arch Med Res 2010; 41: 410-422.
54. Ferrucci L, Cherubini A, Bandinelli S, Bartali B, Corsi A, Lauretani F et al. Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. J Clin Endocrinol Metab 2006; 91: 439-446. (Pubitemid 43236907)
55. Xiao YF, Sigg DC, Leaf A. The antiarrhythmic effect of n-3 polyunsaturated fatty acids: Modulation of cardiac ionic channels as a potential mechanism. J Membr Biol 2005; 206: 141-154. (Pubitemid 43199147)
56. Okuda Y, Kawashima K, Sawada T, Tsurumaru K, Asano M, Suzuki S et al. Eicosapentaenoic acid enhances nitric oxide production by cultured human endothelial cells. Biochem Biophys Res Commun 1997; 232: 487-491. (Pubitemid 27216245)
57. Kris-Etherton PM, Harris WS, Appel LJ. American Heart Association Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002; 106: 2747-2757.
58. Navaneethan SD, Vecchio M, Johnson DW, Saglimbene V, Graziano G, Pellegrini F et al. Prevalence and correlates of self-reported sexual dysfunction in CKD: A meta-analysis of observational studies. Am J Kidney Dis 2010; 56: 670-685.
59. Travallai SA, Mirzamani M, Heshmatzade BA, Assari S, Khoddami Vishteh HR, Hajarizadeh B et al. Sexual function: A comparison between male renal transplant recipients and hemodialysis patients. J Sex Med 2009; 6: 142-148.
60. Fernandes GV, dos Santos RR, Soares W, de Lima LG, de Macedo BS, da Fonte JE et al. The impact of erectile dysfunction on the quality of life of men undergoing hemodialysis and its association with depression. J Sex Med 2010; 7: 4003-4010.
61. Inman BA, St Sauver JL, Jacobson DL, Mcgree ME, Nehra A, Lieber MM et al. A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin Proc 2009; 84: 108-113.
62. Suh JH, Shenvi SV, Dixon BM, Liu H, Jaiswal AK, Liu RM et al. Decline in transcriptional activity of Nrf2 causes agerelated loss of glutathione synthesis, which is reversible with lipoic acid. Proc Natl Acad Sci USA 2004; 101: 3381-3386. (Pubitemid 38338203)
63. Van Mierlo LAJ, Arends LR, Streppel MT, Zeegers MPA, Kok FJ, Grobbee DE et al. Blood pressure response to calcium supplementation: A meta-analysis of randomized controlled trials. J Hum Hypertens 2006; 20: 571-580. (Pubitemid 44088959)
64. Hamilton IM, Gilmore WS, Benzie IF, Mulholland CW, Strain JJ. Interactions between vitamins C and E in human subjects. Br J Nutr 2000; 84: 261-267.
65. Zorgniotti AW, Lizza EF. Effect of large doses of the nitric oxide precursor, L-arginine, on erectile dysfunction. Int J Impot Res 1994; 6: 33-35.
66. Chen J, Wollman Y, Chernichovsky T, Iaina A, Sofer M, Matzkin H. Effect of oral administration of high-dose nitric oxide donor L-arginine in men with organic erectile dysfunction: Results of a double-blind, randomized, placebo-controlled study. BJU Int 1999; 83: 269-273. (Pubitemid 29151525)
67. Klotz T, Mathers MJ, Braun M, Bloch W, Engelmann U. Effectiveness of oral L-arginine in first-line treatment of erectile dysfunction in a controlled crossover study. Urol Int 1999; 63: 220-223. (Pubitemid 30072009)
68. Verit A, Savas M, Ciftci H, Aksoy N, Taskin A, Topal U. Assessment of the acute effects of tadalafil on the cardiovascular system based on examination of serum oxidative status and paraoxonase activity in men with erectile dysfunction: A preliminary study. Int J Impot Res 2010; 22: 115-119.
69. Rosano GMC, Aversa A, Vitale C, Fabbri A, Fini M, Spera G. Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk. Eur Urol 2005; 47: 214-222. (Pubitemid 40126979)
70. Schafer A, Fraccarollo D, Pfortsch S, Flierl U, Vogt C, Pfrang J et al. Improvement of vascular function by acute and chronic treatment with the PDE-5 inhibitor sildenafil in experimental diabetes mellitus. Br J Pharmacol 2008; 153: 886-893. (Pubitemid 351328925)
71. Oliver JJ, Melville VP, Webb DJ. Effect of regular phosphodiesterase type 5 inhibition in hypertension. Hypertension 2006; 48: 622-627. (Pubitemid 44843865)
72. Tonetti MS, D'Aiuto F, Nibali L, Donald A, Storry C, Parkar M et al. Treatment of periodontitis and endothelial function. N Engl J Med 2007; 356: 911-920. (Pubitemid 46339910)
73. Zuo Z, Jiang J, Jiang R, Chen F, Liu J, Yang H et al. Effect of periodontitis on erectile function and its possible mechanism. J Sex Med 2011; 8: 2598-2605.
74. Esposito K, Ciotola M, Giugliano F, De Sio M, Giugliano G, D'armiento M et al. Mediterranean diet improves erectile function in subjects with the metabolic syndrome. Int J Impot Res 2006; 18: 405-410.
75. Meldrum DR, Gambone JC, Morris MA. Erectile-function. Available at: http://erectile-function.com. (accessed 11 September 2011).